New developments in therapeutic agents for Legionnaires' disease

Anti-Infective Agents in Medicinal Chemistry

Volumn 6, Issue 4, 2007, Pages 228-242

  Roig, Jorge ^a   Arnau, Josep M ^b   Vallano, Antoni ^b   Rello, Jordi ^c  

^a UNIVERSITY OF ANDORRA   (Andorra)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Legionnaires' disease; New drugs; Treatment update

Indexed keywords

1 (6 AMINO 3,5 DIFLUORO 2 PYRIDYL) 8 CHLORO 6 FLUORO 1,4 DIHYDRO 7 (3 HYDROXY 1 AZETIDINYL) 4 OXO 3 QUINOLINECARBOXYLIC ACID; 5 AMINO 7 (7 AMINO 5 AZASPIRO[2.4]HEPT 5 YL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 8 METHYL 4 OXO 3 QUINOLINECARBOXYLIC ACID; AZITHROMYCIN; CARBAMAZEPINE; CETHROMYCIN; CLARITHROMYCIN; CYCLOSPORIN; DOXYCYCLINE; DW 286A; ERYTHROMYCIN; ERYTHROMYCIN ESTOLATE; ERYTHROMYCIN ETHYLSUCCINATE; ERYTHROMYCIN GLUCOHEPTONATE; ERYTHROMYCIN LACTOBIONATE; ERYTHROMYCIN STEARATE; EVERNIMICIN; GARENOXACIN; GEMIFLOXACIN; KETOLIDE; LORATADINE; MACROLIDE; MIDAZOLAM; MOXIFLOXACIN; OLAMUFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TELITHROMYCIN; TIGECYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

ACUTE KIDNEY FAILURE; ACUTE PSYCHOSIS; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANAPHYLAXIS; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BILIRUBIN BLOOD LEVEL; BLURRED VISION; BONE; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; COST EFFECTIVENESS ANALYSIS; DELIRIUM; DIARRHEA; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MARKETING; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHILIA; EPIDEMIC; ERYTHEMA; ESOPHAGUS ULCER; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC DISTRIBUTION; GLUCOSE METABOLISM; HALLUCINATION; HEARING LOSS; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HEPATITIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTENSION; IMMUNOCOMPROMISED PATIENT; INJECTION SITE PAIN; INSOMNIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LEUKOPENIA; LIVER DYSFUNCTION; LIVER TOXICITY; LUPUS LIKE SYNDROME; MANIA; MAXIMUM PLASMA CONCENTRATION; MOOD DISORDER; MORTALITY; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NAUSEA; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUROMUSCULAR JUNCTION DISORDER; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; PARANOIA; PHAGOCYTE; PHOTOSENSITIVITY; PHOTOTOXICITY; PIGMENTATION; PROGNOSIS; PROTEIN SYNTHESIS INHIBITION; PSEUDOMEMBRANOUS COLITIS; QT PROLONGATION; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SKIN MANIFESTATION; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ANALYSIS; SUPERINFECTION; TENDINITIS; THROMBOCYTOPENIA; THROMBOPHLEBITIS; TOOTH; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL; URINARY EXCRETION; VISUAL HALLUCINATION; VOMITING;

EID: 35448979945     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152107782023079     Document Type: Article

References (161)

1. Davis, G.S.; Winn, Jr W.C.; Beaty, H.N. Clin. Chest Med., 1981, 2, 145.
2. Yu, V.L.; Kroboth, F.J.; Shonnard, J.; Brown, A.; McDearman, S.; Magnussen, M. Am. J. Med., 1982, 73, 357.
3. Roig, J.; Domingo C.; Morera J. Chest, 1994, 105, 1817
4. Falcó, V.; Fernández de Sevilla, T.; Alegre, J.; Ferrer, A.; Martínez Vázquez, J.M. Chest, 1991, 100, 1007.
5. Roig, J.; Domingo, C. In Severe Community-Acquired Pneumonia; Rello J & Leeper KV, Ed.; Kluwer Academic Publishers: Boston, 2001, pp. 41-56.
6. Stout, J.E.; Yu, V.L. N. Engl. J. Med., 1997, 337, 682.
7. Mills, G.D.; Oehley, M.R.; Arrol, B. B.M.J., 2005, 330, 460.
8. Shefet, D.; Robenshtok, E.; Paul, M.; Leibovici, L. Arch. Intern. Med., 2005, 165, 1992.
9. Roson, B.; Carratala, J.; Fernandez-Sabe, N.; Tubau, F.; Manresa, F.; Gudiol, F. Arch. Intern. Med., 2004, 164, 502.
10. Roig. J.; Aguilar, X.; Ruiz, J.; Domingo, C.; Mesalles, E.; Manterola; J. Chest, 1991, 99, 344.
11. García-Fulgueiras, A.; Navarro. C.; Fenoll, D.; Garcia, J.; Gonzalez-Diego, P.; Jimenez-Bunuales, T. Emerg. Infect. Dis., 2003, 9, 915.
12. Redd, S.C.; Schuster, D.M.; Quan, J.; Plikaytis, B.D.; Spika, J.S.; Cohen, M.L. J. Infect. Dis., 1988, 158, 651.
13. Mathys, W.; Deng, M.C.; Meyer, J.; Junge-Mathys, E. J. Hosp. Infect., 1999, 43, 242.
14. Li Gobbi, F.; Benucci, M.; Del Rosso, A. J. Clin. Rheumatol., 2005, 11, 119.
15. Greenberg, D.; Chiou, C.C.; Famigilleti, R.; Lee, T.C.; Yu, V.L. Lancet Infect. Dis., 2006, 6, 529.
16. Sopena, N.; Force, L.; Pedro-Botet, M.L.; Barrufet, P.; Sauca, G. Eur. Respir. J., 2007, 29, 263
17. Benin, A.L.; Benson, R.F.; Besser, R.E. Clin. Infect. Dis., 2002, 35, 1039.
18. Konig, C.; Hebestreit, H.; Valenza, G.; Abele-Horn, M.; Speer, C.P. Acta Paediatr., 2005, 94, 1505.
19. Fisman, D.N.; Lim, S.; Wellenius, G.A.; Johnson, C.; Britz, P.; Gaskins, M. J. Infect. Dis., 2005, 192, 2066.
20. Yu, V.L.; Plouffe, J.F.; Pastoris, M.C.; Stout, J.E.; Schousboe, M.; Widmer, A. J. Infect. Dis., 2002, 186, 127.
21. Muder, R.R.; Yu, V.L. Clin. Infect. Dis., 2002, 35, 990.
22. Muder, R.R.; Stout, J.E.; Yu. V.L. Am. J. Med., 2000, 108, 346.
23. Blatt, S.P.; Parkinson, M.D.; Pace, E.; Hoffman, P.; Dolan, D.; Lauderdale, P.; Zajac, R.A.; Melcher, G.P. Am. J. Med., 1993, 95, 16.
24. Johnson, J.T.; Yu, V.L.; Best; M.; Vickers, R.M.; Goetz, A.; Wagner, R. Lancet, 1985, 2, 298.
25. Roig, J.; Sabria, M.; Pedro-Botet, M.L. Curr. Op. Infect. Dis., 2003, 16, 145.
26. Sabria, M.; Yu, V.L. Lancet Infect. Dis., 2002, 2, 368.
27. Pedro-Botet, M.L.; Stout, J.E.; Yu, V.L. Eur. J. Clin. Microbiol. Infect. Dis., 2002, 21, 699.
28. Skogberg, K.; Nuorti, J.P.; Saxen, H.; Kustnetsov, J.; Mentula, S.; Fellman, V.; Maki-Petays, N.; Jousimies-Somer, H. Clin. Infect. Dis., 2002, 35, e82.
29. Granados, A.; Podzamczer, D.; Gudiol, F.; Manresa, F. Eur. Respir. J., 1989, 2, 130.
30. Macfarlane, J.T.; Miller, A.C.; Roderick Smith, W.H.; Morris, A.H.; Rose, D.H. Thorax, 1984, 39, 28.
31. Woodhead, M.A.; Macfarlane, J.T. Br. J. Dis. Chest, 1987, 81, 133.
32. Fernandez-Sabe, N.; Roson, B.;-Carratala, J.; Dorca, J.; Manresa, F.; Gudiol, F. Clin. Infect. Dis., 2003, 37, 483.
33. Castor, M.L.; Wagstrom, E.A.; Danila, R.N.; Smith, K.E.; Naimi, T.S.; Besser, J.M. J. Infect. Dis., 2005; 191, 1530.
34. Spieker. S.; Petersen, D.; Rolfs, A.; Fehrenbach, F.; Kuntz, R.; Seuffer, R.H.; Fetter, M.; Dichgans, J. Eur. Neurol., 1998, 40, 169.
35. Rudin, J.E.; Evans, T.L.; Wing, E.J. Am. J. Med., 1984, 76, 318.
36. Diederen, B.M.; van Zwet, A.A.; van der Zee, A.; Peeters, M.F. Eur. J. Clin. Microbiol. Infect. Dis., 2005, 24, 545.
37. Faris, B.; Faris, C.; Schousboe, M.; Heath, C.H. Emerg. Infect. Dis., 2005, 11, 1405.
38. Bentz, J.S.; Carroll, K.; Ward, J.H.; Elstad, M.; Marshall C.J. Diagn. Cytopathol., 2000, 22, 45.
39. Amsden, G.W. J. Antimicrob. Chemother., 2005, 55, 10.
40. Roig. J.; Carreres, A.; Domingo, C. Drugs, 1993, 46, 63.
41. Gacouin, A.; Le Tulzo, Y.; Lavoue, S.; Camus, C.; Hoff, J.; Bassen, R.; Arvieux, C.; Heurtin, C.; Thomas R. Inten. Care Med., 2002, 28, 686.
42. Roig, J.; Rello, J. In Legionella: State of the Art 30 Years After its Recognition; Ciancioto N, Ed, ASM Press, Washington, 2006.
43. Edelstein, P.H. Ann. Intern. Med., 1998, 129, 328.
44. Roig, J.; Rello, J. J.A.C., 2003, 51, 1119.
45. Benhamou, D.; Bru, J.P.; Chidiac, C.; Étienne, J.; Léophonte, P.; Marty, N.; Poirier, R.; Rouquet, R.M. Med. Mal. Infect., 2005, 35, 1
46. Chidiac, C.; Maulin, L. Med. Mal. Infect., 2003, 33, 549.
47. Edelstein, P.H. In Legionella; Marre, R. Ed.; ASM Press: Washington DC, 2002, pp. 183-88.
48. Mykietiuk, A.; Carratalà, J.; Fernández-Sabe, N.; Dorca, J.; Verdaguer, R.; Manresa, F.; Gudiol, F. Clin. Infect. Dis., 2005, 40, 794.
49. Blázquez, R.M.; Espinosa, F.J.; Alemany, L.; Ramos, R.M.; Sánchez-Nieto, J.M.; Segovia, M.; Serrano, J.A.; Herrero, F. Clin. Infect. Dis., 2005, 40, 800.
50. Sabrià, M.; Pedro-Botet, M.L.; Gómez, J.; Roig, J.; Vilaseca, B.; Sopena, N.; Baños, V.; and Legionnaires' Disease Therapy Group. Chest, 2005, 128, 1401.
51. Kraus, C.N.; Zalkikar, J.; Powers, J.H. Clin. Infect. Dis., 2005, 41, 416.
52. Zhanel, G.G.; Dueck, M.; Hoban, D.J., Vercaigne, L.M., Embil, J.M.; Gin, A.S.; Karlowsky, J.A. Drugs, 2001, 61, 443.
53. Howden, B.P.; Stuart, R.L.; Tallis, G.; Bailey, M.; Johnson, P.D. Intern. Med. J., 2003, 33, 484.
54. Segreti, J.; Meyer, P.; Kapell, K. Diagn. Microbiol. Infect. Dis., 1996, 25, 123.
55. Sivapalasingam, U.; Steigbigel, IH. In Principles and practice of infectious diseases; Mandell, G.L.; Douglas, R.G.; Bennett, J.E., Ed; Churchill-Livingstone: New York, 2005, pp. 396-417.
56. Amsden, G.W. Chapter 46. In Principles and practice of infectious diseases; Mandell, G.L.; Douglas, R.G.; Bennett, J.E., Ed; Curchill-Livingstone: New York, 2005, pp. 635-685.
57. Osono, T.; Umezawa, H. J. Antimicrob. Chemother., 1995, 16(Suppl A), 151.
58. Hand, W.L.; Corwin, R.W.; Steinberg, T.H.; Grossman, G.D. Am.Rev.Respir.Dis., 1984, 129, 933.
59. Miller, M.F.; Martin, J.R.; Johnson, P.; Ulrich, J.T.; Rdzok, E.J.; Billing, P. J. Infect. Dis., 1984, 149, 714.
60. Krause, M.; Ruef, C. In Meyler's side effects of drugs; Dukes, M.N.G.; Aronson, J.K., Eds.; Elsevier: Amsterdam, 2000, pp. 871-895.
61. Murdoch, J. Can. J. Hosp. Pharm., 1998, 41, 277.
62. Katapadi, K.; Kostandy, M.; Katapadi, M.; Hussain, K.M.; Schifter, D. Angiology, 1997, 48, 821.
63. Swanson, D.J.; Sung, R.J.; Fine, M.J.; Orloff, J.J.; Chu, S.Y.; Yu, V.L. Am. J. Med., 1992, 92, 61.
64. Amsden, G.W. Ann. Pharmacother., 1995, 29, 906.
65. Fitzgeorge, R.B.; Lever, S.; Baskerville, A. J. Antimicrob. Chemother., 1993, 31(Suppl E), 171.
66. Hopkins, S. Am. J. Med., 1991, 91(3A), 40S.
67. Hardy, D.J.; Guay, D.R.; Jones, R.N. Diagn. Microbiol. Infect. Dis., 1992, 15, 39.
68. Schentag, J.J.; Ballow, C.H. Am. J. Med., 1991, 91(3A), 5S.
69. Anderson, R.; Joone G.; van Rensburg, C.E. J. Antimicrob. Chemother., 1988, 22, 923.
70. Ballow, C.H.; Amsden, G.W. Ann. Pharmacother., 1992, 26, 1253.
71. Celis, G.; Gea, E.; Roig, J.; Latorre, J.; Martínez, J.; Gomez, J. Clin. Drug Invest. 2002, 22, 393.
72. Cone, L.A.; Sneider, R.A.; Nazemi, R.; Dietrich, E.J. Clin. Infect. Dis., 1996, 22, 595.
73. Kim, R. The Medical Letter Handbook of Adverse Drug Interactions. The Medical letter on Drugs and Therapeutics: New Rochelle, NY, 2003.
74. Takahashi, H.; Hayakawa, I.; Akimoto, T. Yakushigaku Zasshi, 2003, 38, 161.
75. Domagala, J.M. J. Antimicrob. Chemother., 1994, 33, 685.
76. Domagala, J.M.; Hagen, S.E. In: Quinolone Antimicrobial Agents; Hooper, D.C.; Rubinstein, E., Eds; ASM Press: Washington, 2003, pp. 3-18.
77. Drlica, K.; Hooper, D.C. In: Quinolone Antimicrobial Agents; Hooper, D.C.; Rubinstein, E., Eds; ASM Press: Washington, 2003, pp. 19-40.
78. Stout, J.E.; Sens, K.; Mietzner, S.; Obman, A.; Yu, V.L. Int. J. Antimicrob. Agent, 2005, 25, 302.
79. Pedro-Botet, L.; Yu, V.L. Clin. Microbiol. Infect., 2006, 12(Suppl 3), 25.
80. Stout, J.E.; Arnold, B.; Yu, V.L. Diagn. Microbiol. Infect. Dis., 1998, 30, 37.
81. Baltch, A.L.; Bopp, L.H.; Smith, R.P.; Michelsen, P.B.; Ritz, W.J. J. Antimicrob. Chemother., 2005, 56, 104.
82. Dedicoat, M.; Venkatesan, P. J. Antimicrob. Chemother., 1999, 43, 747.
83. Qaqish, R.; Polk, R.E. In: Quinolone Antimicrobial Agents; Hooper, D.C.; Rubinstein, E., Eds; ASM Press: Washington, 2003, pp. 133-146.
84. Freeman, C.D.; Nicolau, D.P.; Belliveau, P.P.; Nightingale, C.H. Clin. Pharmacokinet., 1993, 25, 6.
85. Dudley, MN. In: Quinolone Antimicrobial Agents; Hooper, D.C.; Rubinstein, E., Eds; ASM Press: Washington, 2003, pp. 115-132.
86. Giamarellou, H.; Kolokythas, E.; Petrikkos, G.; Gazis, J.; Aravantinos, D.; Sfikakis, P. Am. J. Med., 1989, 87(5A), 49S.
87. Cahill, J.B.; Bailey, E.M.; Chien, S.; Johnson, G.M. Pharmacotherapy, 2005, 25, 116.
88. Polachek, H.; Holcberg, G.; Sapir, G.; Tsadkin-Tamir, M.; Polachek, J.; Katz, M.; Ben-Zvi, Z. Eur. J. Obstet. Gynecol. Reprod. Biol., 2005, 122, 61.
89. Rubinstein, E. Chemotherapy, 2001, 47 (Suppl 3), 3.
90. Lode, H.; Rubinstein, E. In: Quinolone Antimicrobial Agents; Hooper, D.C.; Rubinstein, E., Eds; ASM Press: Washington, 2003, pp. 407-419.
91. Ruef, C.; Blaser, J. In Meyler's side effects of drugs; Dukes, M.N.G.; Aronson, J.K., Eds.; Elsevier Amsterdam, 2000, pp. 837-870.
92. Loebstein, R.; Addis, A.; Ho, E.; Andreou, R.; Sage, S.; Donnenfeld, A.E.; Schick, B.; Bonati, M.; Moretti, M.; Lalkin, A.; Pastuszak, A.; Koren, G. Antimicrob. Agents Chemother., 1998, 42, 1336.
93. van der Linden, P.D.; Sturkenboom, M.C.; Herings, R.M.; Leufkens, H.M.; Rowlands, S.; Stricker, BH. Arch. Intern. Med., 2003, 163, 1801.
94. Yap, Y.G.; Camm, A.J. In: Quinolone Antimicrobial Agents; Hooper, D.C.; Rubinstein, E., Eds; ASM Press: Washington, 2003, pp. 421-440.
95. Gajjar, D.A.; LaCreta, F.P.; Kollia, G.D.; Stolz, R.R.; Berger, S.; Smith, W.B.; Swingle, M.; Grasela, D.M. Pharmacotherapy, 2000, 20, 76S.
96. Park-Wyllie, L.Y.; Juurlink, D.N.; Kopp, A.; Shah, B.R.; Stukel, T.A.; Stumpo, C.; Dresser, L.; Low, D.E.; Mamdani, M.M. N. Engl. J. Med., 2006, 354, 1352.
97. Calfee, D.P. In Principles and practice of infectious diseases; Mandell, G.L.; Douglas, R.G.; Bennett, J.E., Ed; Curchill-Livingstone: New York, 2004, pp. 374-388.
98. Baltch, A.; Smith, R.; Ritz, W. Antimicrob. Agents Chemother., 1995, 39, 1661.
99. Dourmon, E.; Mayaud, C.; Wolff, M.; Schlemmer, B.; Samuel, D.; Sollet, J.P.; Levasseur-Rajagopalan, P. J. Antimicrob. Chemother., 1990, 26(Suppl B), 129.
100. Mandell LA.; Wunderink RG.; Anzueto A.; Barlett, J.G.; Campbell GD.; Dean NC.; Dowell SF.; File, T.M.; Musher, D.M.;Niederman MS.; Torres A.; Whitney CG. Clin. Infect. Dis., 2007, 44(Suppl 2), S27.
101. Zent, C.; Smith. P. Tuber. Lung Dis., 1995, 76, 109.
102. Leuenberger P, Zellweger JP. In Meyler's side effects of drugs; Dukes, M.N.G.; Aronson, J.K., Eds.; Elsevier. Amsterdam, 2000, pp. 1005-1029.
103. Cook, S.V.; Fujiwara, P.I.,: Frieden, T.R. Int. J. Tuberc. Lung Dis., 2000, 4, 118.
104. Thornsberry, C.; Baker, C.N.; Kiiven, L.A. Antimicrob. Agents Chemother., 1978, 13, 78.
105. Saivin, S.; Houin, G. Clin. Pharmacokinet., 1988, 15, 355.
106. Joshi, N.; Miller, D.Q. Arch. Intern. Med., 1997, 157, 1421.
107. Brumfitt, W.; Hamilton-Miller, J.M. J. Chemother., 1995, 7, 136.
108. Masters, P.A.; O'Bryan, T.A.; Zurlo, J.; Miller, D.Q.; Joshi, N. Arch Intern. Med., 2003, 163, 402.
109. Howe, R.A.; Spencer, R.C. Drug. Saf., 1996, 14, 213.
110. Forna, F.; McConnell, M.; Kitabire, F.N.; Homsy, J.; Brooks, J.T.; Mermin, J.; Weidle, P.J. AIDS Rev., 2006, 8, 24.
111. Sivojelezova, A.; Einarson, A.; Shuhaiber, S.; Koren, G. Can. Fam. Physician., 2003, 49, 1085.
112. Zhanel, G.G.; Walters, M.; Noreddin, A.; Vercaigne, L.M.; Wierzbowski, A.; Embil, J.M.; Gin, A.S.; Douthwaite, S.; Hoban, D.J. Drugs, 2002, 62, 1771.
113. Ma, Z.; Nemoto, P.A. Curr. Med. Chem. Anti-Infective Agents, 2002, 1, 15.
114. Shain, C.S.; Amsden, G.W. Ann. Pharmacother., 2002, 36, 52.
115. Anonimous. Pharma A. Ketek (telithromycin) briefing document for the FDA anti-infective drug products advisory committee [executive summary]. Bridgewater, NJ: Aventis Pharma; 2001. http://www.fda.gov/ohrms/ dockets/ac/03/briefing/3919B1_01_Aventis-KETEK.pdf.
116. Carbon, C.; Nusrat, R. Eur. J. Clin. Microbiol. Infect. Dis., 2004, 23, 650.
117. Anonymous. Ketek. European Public Assessment Report (rev. 4). EMEA.Published21/07/06. http://www.emea.cu.int/humandocs/Humans/EPAR/ ketek/ketek.htm.
118. Anonymous. Clin. Infect. Dis., 2003, 36, i.
119. Clay, K.D.; Hanson, J.S.; Pope, S.D.; Rissmiller, R.W.; Purdum, P.P.; Banks, P.M. Ann. Intern. Med., 2006, 144, 415.
120. Champney, W.S.; Tober, C.L. Curr. Microbiol., 2001, 42, 203.
121. Ono, T.; Kashimura, M.; Suzuki, K.; Oyauchi, K.; Miyachi, J.; Ikuta, H.; Kawauchi, H.; Akashi, T.; Asaka, T.; Morimoto, S. J. Antibiot (Tokyo), 2004, 57, 518.
122. Edelstein, P.H.; Higa, F.; Edelstein, M.A. Antimicrob. Agents Chemother., 2001, 45, 2685.
123. Pradhan, R.S.; Gustavson, L.E.; Londo, D.D.; Shang, J.; Zhang, J,; Paris, M. [abstract no.2135]. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2000 Sept 17-20; Toronto, Canada.
124. Conte, J.E.; Golden, J.A.; Kipps, J.; Zurlinden, E. Antimicrob. Agents Chemother., 2004, 48, 3508.
125. Bhavnani, S.M.; Andes, D.R. Pharmacotherapy, 2005, 25, 717
126. Edelstein, P.H.; Shinzato, T.; Doyle, E.; Edelstein, M.A., Antimicrob. Agents Chemother., 2001, 45, 2204.
127. Santos, J.; Aguilar, L.; Garcia-Mendez, E.; Siquier, B.; Custardoy, J.; Garcia-Rey, C.; and 049 Cap Collaborative Study Group. J. Chemother., 2003, 15, 461.
128. Abramowicz, M. Med. Lett. Drugs Ther., 2004, 46, 78.
129. Dubois, J.; St-Pierre, C. Diagn. Microbiol. Infect. Dis., 2001, 41, 79.
130. Edelstein, P.H.; Shinzato, T.; Edelstein, M.A. J. Antimicrob. Chemother., 2001, 48, 667.
131. Gajjar, D.A.; Bello, A.; Ge, Z.; Christopher, L.; Grasela, D.M. Antimicrob. Agents Chemother., 2003, 47, 2256.
132. Van Wart, S.; Phillips, L,; Ludwig, E.A.; Russo, R.; Gajjar, D.A.; Bello, A. Antimicrob. Agents Chemother., 2004, 48, 4766.
133. Higa, F.; Arakaki, N.; Tateyama, M.; Koide, M.; Shinzato, T.; Kawakami, K.; Saito, A. J. Antimicrob. Chemother., 2003, 52,920.
134. Murata, M.; Tamai, I.; Sai, Y.; Nagata, O.; Kato, H.; Tsuji, A. J. Pharmacol. Exp. Ther., 1999, 289, 79.
135. Murata, M.; Tamai, I.; Sai, Y.; Nagata, O.; Kato, H.; Sugiyama, Y.; Tsuji, A. Drug Metab. Dispos., 1998, 26, 1113.
136. Umemura, K.A.; Nakashima, M. 1996. abstr. F60, p. 110. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
137. Nilius, A.M.; Shen, L.L.; Hensey-Rudloff, D.; Almer, L.S.; Beyer, J.M.; Balli, D.J. Antimicrob. Agents Chemother., 2003, 47, 3260.
138. Kim, E.J.; Shin, W.H. Biol. Pharm. Bull., 2004, 27, 641.
139. Zhanel, G.G.; Homenuik, K.; Nichol, D.; Noreddin, A.; Vercaigne, L.; Embil, J.; Gin, A.; Karlowsky, J.a.; Hoba, D.J. Drugs, 2004, 64, 63.
140. Frampton, J.E.; Curran, M.P. Drugs, 2005, 65, 2623.
141. Edelstein, P.H.; Weiss, W.J.; Edelstein, M.A.C. Antimicrob. Agents Chemother., 2003, 47, 533.
142. Maertens, J.A. IDrugs, 1999, 2, 446.
143. Edelstein, P.H.; Edelstein, M.A. Diagn. Microbiol. Infect. Dis., 1999, 33, 59.
144. Brieland, J.K.; Loebenberg, D.;.Menzel, F.; Hare, R.S. Antimicrob. Agents Chemother., 2000, 44, 1333.
145. Kozawa, O.; Uematsu, T.; Matsuno, H.; Niwa, M.; Kohno, K.; Kawato, A.; Takahashi, K.; Nagashima, S.; Kanamaru, M. Antimicrob. Agents Chemother., 2001, 45, 917.
146. Nagashima, S.; Niwa, M.; Nishiki, K.; Hosoya, T.; Hishida, A.; Uematsu, T. Eur. J. Clin. Pharmacol., 2004, 60, 255.
147. Edelstein, P.H.; Hu, B.; Edelstein, M.A. Antimicrob. Agents Chemother., 2005, 49, 2533.
148. Bodi, M.; Rodríguez, A.; Solé-Violan, J.; Gilavert, M.C.; Garnacho, J.; Blanquer, J.; Jiménez, J.; de la Torre, M.V.; Sirvent, J.M.; Almirall, J.; Doblas, A.; Badía, J.R.; Garcia, F.; Mendía, A.; Jordà, R.; Bobillo, F.; Vallés, J.; Broch, M.J.; Carrasco, N.; Herranz, M.A.; Rello, J. for the Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators. Clin. Infect. Dis., 2005, 41, 1709.
149. Hubbard, R.B.; Mathur, R.M.; MacFarlane, J.T. Q. J. Med., 1993, 86, 327.
150. Plouffe, J.F.; Breiman, R.F.; Fields, B.S.; Herbert, M.; Inverso, J.; Knirsch, C.; Kolokathis, A.; Marrie, T.J.; Nicolle, L.; Schwartz, D.B. Clin. Infect. Dis., 2003, 37, 1475.
151. Roig, J.; Casal, J.; Gispert, P.; Gea, E. Med. Mal. Infect., 2006, 36, 680
152. Sanchez, F.; Mensa, J.; Martinez. J.A.; Garcia, E.; Marco, F.; Gonzalez, J. Clin. Infect. Dis., 2003, 36, 1239.
153. Dunbar, L.M.; Khashab, M.M.; Kahn, J.B.; Zadeikis, N.; Xiang, J.X.; Tennenberg, A.M. Curr. Med. Res. Opin., 2004, 20, 555.
154. Yu, V.L; Greenberg, R.N.; Zadeikis, N.; Stout I.E.; Khashab, M.M.; Olson, W.H.; Tennenberg, A.M. Chest, 2004, 125, 2135.
155. Reilly, K.M.; Urban, M.A.; Barreiro, T.; Betts, R.F.; Trawick, D.R. Clin. Infect. Dis., 2005, 40, e87.Nara, C.; Tateda, K.; Matsumoto, T.; Ohara, A.; Miyazaki, S.; Standiford, T.J.; Yamaguchi, K. J. Med. Microb., 2004, 53, 727.
156. Almirall, J.; Bolibar, I.; Toran, P.; Pera, G.; Boquet, X.; Balanzo, X. Chest, 2004, 125, 1335.
157. Franzin, L.; Cabodi, D. Curr. Microbiol., 2005, 50, 43.
158. Prat, C.; Dominguez, J.; Andreo, F.; Blanco, S.; Pallares, A.; Cuchillo, F. J. Infect., 2005, 52, 169
159. Harris, D.J.; Duke, G.J.; McMillan, J. Crit. Care Resusc., 2002, 4, 28.
160. Bodur, H.; Savran, Y.; Koca, U.; Kilinc, O.; Albayrak, S.; Itil, O.; Akoglu, S. Eur. J. Anaesth., 2006, 23, 806.
161. Nara, C.; Tateda, K.; Matsumoto, T. J. Med. Microb., 2004, 33, 727.